• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉穿刺的质量和时机对健康中年男性血液凝固标志物的影响。

The effects of quality and timing of venepuncture on markers of blood coagulation in healthy middle-aged men.

作者信息

Miller G J, Bauer K A, Barzegar S, Foley A J, Mitchell J P, Cooper J A, Rosenberg R D

机构信息

Medical Research Council Epidemiology and Medical Care Unit, London, UK.

出版信息

Thromb Haemost. 1995 Jan;73(1):82-6.

PMID:7740501
Abstract

Effects of the quality and the time of venepuncture on factor VII coagulant activity (VIIc) and the concentrations of fibrinogen, prothrombin fragment 1 + 2 (F1 + 2) and fibrinopeptide A (FPA) were sought in 2665 men, of whom 2334 were re-examined after about one year. Venepunctures were categorised as satisfactory, not fully satisfactory or unsatisfactory according to pre-defined criteria. Neither the quality nor timing of the venepuncture influenced VIIc or fibrinogen concentration. However, at baseline and re-examination F1 + 2 and FPA were increased on average by about 9% and 45% respectively when venepunctures were not fully satisfactory, and by about 11% and 100% when unsatisfactory. Plasma collected after 1500 h had slightly but significantly lower levels of F1 + 2 and FPA than samples taken earlier, possibly due to circadian rhythm. The results emphasise the need for careful surveillance of the venepuncture procedure and the value of FPA when using F1 + 2 as a marker of risk of thrombosis.

摘要

在2665名男性中研究了静脉穿刺质量和时间对凝血因子VII促凝活性(VIIc)、纤维蛋白原浓度、凝血酶原片段1 + 2(F1 + 2)和纤维蛋白肽A(FPA)的影响,其中2334人在大约一年后接受了复查。根据预先定义的标准,静脉穿刺被分类为满意、不完全满意或不满意。静脉穿刺的质量和时间均未影响VIIc或纤维蛋白原浓度。然而,在基线和复查时,当静脉穿刺不完全满意时,F1 + 2和FPA平均分别增加约9%和45%,当不满意时分别增加约11%和100%。1500 h后采集的血浆中F1 + 2和FPA水平略低于但显著低于较早采集的样本,这可能归因于昼夜节律。结果强调了在使用F1 + 2作为血栓形成风险标志物时仔细监测静脉穿刺程序的必要性以及FPA的价值。

相似文献

1
The effects of quality and timing of venepuncture on markers of blood coagulation in healthy middle-aged men.静脉穿刺的质量和时机对健康中年男性血液凝固标志物的影响。
Thromb Haemost. 1995 Jan;73(1):82-6.
2
Fibrin D-dimer, markers of coagulation activation and the risk of major ischaemic heart disease in the caerphilly study.纤维蛋白D - 二聚体,卡菲利研究中凝血激活的标志物及主要缺血性心脏病风险
Thromb Haemost. 2001 Sep;86(3):822-7.
3
Activation of the coagulant pathway in cigarette smokers.
Thromb Haemost. 1998 Mar;79(3):549-53.
4
Relationship of waist and hip circumference with coagulation and fibrinolysis in postmenopausal women.绝经后女性腰围和臀围与凝血及纤溶的关系
Clin Sci (Lond). 2007 Nov;113(9):383-91. doi: 10.1042/CS20070084.
5
Plasma protein oxidation is associated with an increase of procoagulant markers causing an imbalance between pro- and anticoagulant pathways in healthy subjects.血浆蛋白氧化与促凝血标志物增加有关,这会导致健康受试者体内促凝血和抗凝血途径失衡。
Thromb Haemost. 2002 Jan;87(1):58-67.
6
Prothrombin fragment 1 + 2, thrombin-antithrombin III-complexes and fibrinopeptide A in spontaneously clotting whole blood in vitro. Effects of heparin addition and antithrombin III deficiency.体外自凝全血中的凝血酶原片段1+2、凝血酶-抗凝血酶III复合物及纤维蛋白肽A。添加肝素及抗凝血酶III缺乏的影响。
Thromb Haemost. 1994 Jan;71(1):49-53.
7
Gemfibrozil reduces plasma prothrombin fragment F1 + 2 concentration, a marker of coagulability, in patients with coronary heart disease.
Thromb Haemost. 1992 May 4;67(5):503-6.
8
Coagulation and fibrinolytic markers in a two-month follow-up of coronary bypass surgery.冠状动脉搭桥手术两个月随访中的凝血和纤溶标志物
J Thorac Cardiovasc Surg. 2003 Feb;125(2):336-43. doi: 10.1067/mtc.2003.2.
9
Activation of coagulation and deep vein thrombosis after bone marrow harvesting and insertion of a Hickman-catheter in ABMT patients with malignant lymphoma.恶性淋巴瘤自体骨髓移植患者进行骨髓采集及插入Hickman导管后凝血激活与深静脉血栓形成
Bone Marrow Transplant. 1996 Apr;17(4):577-81.
10
Effects of isoflavones on the coagulation and fibrinolytic system of postmenopausal women.异黄酮对绝经后女性凝血和纤溶系统的影响。
Nutrition. 2008 Feb;24(2):120-6. doi: 10.1016/j.nut.2007.10.009. Epub 2007 Dec 11.

引用本文的文献

1
Metabolic Dysregulation of the Lysophospholipid/Autotaxin Axis in the Chromosome 9p21 Gene SNP rs10757274.9p21 基因 SNP rs10757274 处的溶血磷脂酸/自分泌运动因子轴的代谢失调。
Circ Genom Precis Med. 2020 Jun;13(3):e002806. doi: 10.1161/CIRCGEN.119.002806. Epub 2020 May 12.
2
A 19-SNP coronary heart disease gene score profile in subjects with type 2 diabetes: the coronary heart disease risk in type 2 diabetes (CoRDia study) study baseline characteristics.2型糖尿病患者的19个单核苷酸多态性冠心病基因评分概况:2型糖尿病中的冠心病风险(CoRDia研究)研究基线特征
Cardiovasc Diabetol. 2016 Oct 3;15(1):141. doi: 10.1186/s12933-016-0457-7.
3
Effect of SORT1, APOB and APOE polymorphisms on LDL-C and coronary heart disease in Pakistani subjects and their comparison with Northwick Park Heart Study II.
SORT1、载脂蛋白B(APOB)和载脂蛋白E(APOE)基因多态性对巴基斯坦人群低密度脂蛋白胆固醇(LDL-C)及冠心病的影响及其与诺斯维克公园心脏研究II的比较
Lipids Health Dis. 2016 Apr 26;15:83. doi: 10.1186/s12944-016-0253-0.
4
Influence of Genetic Risk Factors on Coronary Heart Disease Occurrence in Afro-Caribbeans.遗传风险因素对非洲裔加勒比人心血管疾病发生的影响。
Can J Cardiol. 2016 Aug;32(8):978-85. doi: 10.1016/j.cjca.2016.01.004. Epub 2016 Jan 14.
5
Risk Stratification for Primary Prevention of Coronary Artery Disease: Roles of C-Reactive Protein and Coronary Artery Calcium.冠状动脉疾病一级预防的风险分层:C反应蛋白和冠状动脉钙化的作用。
Curr Cardiol Rep. 2015 Dec;17(12):110. doi: 10.1007/s11886-015-0666-9.
6
Clinical Utility of a Coronary Heart Disease Risk Prediction Gene Score in UK Healthy Middle Aged Men and in the Pakistani Population.冠心病风险预测基因评分在英国健康中年男性和巴基斯坦人群中的临床应用
PLoS One. 2015 Jul 2;10(7):e0130754. doi: 10.1371/journal.pone.0130754. eCollection 2015.
7
Population genomics of cardiometabolic traits: design of the University College London-London School of Hygiene and Tropical Medicine-Edinburgh-Bristol (UCLEB) Consortium.心脏代谢特征的人群基因组学:伦敦大学学院-伦敦卫生与热带医学院-爱丁堡大学-布里斯托大学(UCLEB)联盟的设计。
PLoS One. 2013 Aug 20;8(8):e71345. doi: 10.1371/journal.pone.0071345. eCollection 2013.
8
Apolipoprotein E genotype, cardiovascular biomarkers and risk of stroke: systematic review and meta-analysis of 14,015 stroke cases and pooled analysis of primary biomarker data from up to 60,883 individuals.载脂蛋白 E 基因型、心血管生物标志物与卒中风险:14015 例卒中病例的系统评价和荟萃分析及多达 60883 例个体的主要生物标志物数据的汇总分析。
Int J Epidemiol. 2013 Apr;42(2):475-92. doi: 10.1093/ije/dyt034.
9
Human apolipoprotein E isoforms differentially affect bone mass and turnover in vivo.人载脂蛋白 E 异构体在体内对骨量和周转率有不同影响。
J Bone Miner Res. 2013 Feb;28(2):236-45. doi: 10.1002/jbmr.1757.
10
A genetic instrument for Mendelian randomization of fibrinogen.用于纤维蛋白原孟德尔随机化的遗传工具。
Eur J Epidemiol. 2012 Apr;27(4):267-79. doi: 10.1007/s10654-012-9666-x. Epub 2012 Mar 3.